Emmennar Pharma Containers Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 1.40 Cr
as on 21-06-2024
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.71 Cr
as on 21-06-2024
- Satisfied Charges ₹ 2.50 M
as on 21-06-2024
- Revenue 15.26%
(FY 2021)
- Profit 19.36%
(FY 2021)
- Ebitda 22.14%
(FY 2021)
- Net Worth 21.55%
(FY 2021)
- Total Assets 17.89%
(FY 2021)
About Emmennar Pharma Containers
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.40 Cr.
The company currently has active open charges totaling ₹2.71 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Venkatanarayana Mundla and Mundla Reddy serve as directors at the Company.
- CIN/LLPIN
U21014TG2001PTC037859
- Company No.
037859
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Sep 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Emmennar Pharma Containers?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatanarayana Mundla  | Director | 03-Aug-2003 | Current |
| Mundla Reddy | Whole-Time Director | 24-Aug-2007 | Current |
Financial Performance of Emmennar Pharma Containers.
Emmennar Pharma Containers Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 15.26% increase. The company also saw a substantial improvement in profitability, with a 19.36% increase in profit. The company's net worth Soared by an impressive increase of 21.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emmennar Pharma Containers?
In 2021, Emmennar Pharma Containers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 10 Mar 2005 | ₹2.71 Cr | Open |
State Bank Of India Creation Date: 11 Mar 2005 | ₹2.50 M | Satisfied |
How Many Employees Work at Emmennar Pharma Containers?
Emmennar Pharma Containers has a workforce of 27 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emmennar Pharma Containers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emmennar Pharma Containers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
